NXP Semiconductors Files Q3 2024 10-Q

Ticker: NXPI · Form: 10-Q · Filed: Nov 5, 2024 · CIK: 1413447

Nxp Semiconductors N.V. 10-Q Filing Summary
FieldDetail
CompanyNxp Semiconductors N.V. (NXPI)
Form Type10-Q
Filed DateNov 5, 2024
Risk Levellow
Pages16
Reading Time19 min
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-filing, financials

Related Tickers: NXPI

TL;DR

NXPI Q3 24 10-Q filed. Financials updated.

AI Summary

NXP Semiconductors N.V. filed its 10-Q for the period ending September 29, 2024. The filing covers the third quarter of 2024 and provides financial updates. Key financial data and operational details are presented for the reporting period.

Why It Matters

This filing provides investors with the latest financial performance and operational status of NXP Semiconductors, a major player in the automotive and industrial semiconductor markets.

Risk Assessment

Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.

Key Players & Entities

  • NXP Semiconductors N.V. (company) — Filer of the 10-Q
  • 20240929 (date) — End of the reporting period
  • 20241105 (date) — Filing date

FAQ

What is the reporting period for this 10-Q filing?

The reporting period for this 10-Q filing is the quarter ended September 29, 2024.

When was this 10-Q filed with the SEC?

This 10-Q was filed on November 5, 2024.

What is the company's Central Index Key (CIK)?

The company's Central Index Key is 0001413447.

What is NXP Semiconductors N.V.'s fiscal year end?

NXP Semiconductors N.V.'s fiscal year ends on December 31.

What was the previous company name before the name change on September 25, 2007?

The previous company name was KASLION Acquisition B.V.

Filing Stats: 4,801 words · 19 min read · ~16 pages · Grade level 17.6 · Accepted 2024-11-05 07:06:13

Filing Documents

Financial Statements

Financial Statements 3 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 18 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 31 Item 4.

Controls and Procedures

Controls and Procedures 31 Part II Item 1.

Legal Proceedings

Legal Proceedings 32 Item 1A.

Risk Factors

Risk Factors 32 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 32 Item 5. Other Information 32 Item 6. Exhibits 33 Introduction and Forward Looking Statements This Form 10-Q and certain information incorporated herein by reference contains forward-looking statements, which are provided under the "safe harbor" protection of the Private Securities Litigation Reform Act of 1995. When used in this Form 10-Q, the words "anticipate", "believe", "estimate", "forecast", "expect", "intend", "plan" and "project" and similar expressions, as they relate to us, our management or third parties, identify forward-looking statements. Forward-looking statements include statements regarding our business strategy, financial condition, results of operations, market data as well as any other statements that are not historical facts. These statements reflect beliefs of our management, as well as assumptions made by our management and information currently available to us. Although we believe that these beliefs and assumptions are reasonable, these statements are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. These factors, risks and uncertainties expressly qualify all subsequent oral and written forward-looking statements attributable to us or persons acting on our behalf and include, in addition to those listed in our Annual Report on Form 10-K for the year ended December 31, 2023 under Part I, Item 1A. Risk Factors and elsewhere in this Form 10-Q, the following: market demand and semiconductor industry conditions; our ability to successfully introduce new technologies and products; the demand for the goods into which our products are incorporated; trade disputes between the U.S. and China, potential increase of barriers to international trade and resulting disruptions to our established supply chains; the impact of government actions and regulatio

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) ($ in millions, unless otherwise stated) For the three months ended For the nine months ended September 29, 2024 October 1, 2023 September 29, 2024 October 1, 2023 Revenue 3,250 3,434 9,503 9,854 Cost of revenue ( 1,384 ) ( 1,469 ) ( 4,062 ) ( 4,238 ) Gross profit 1,866 1,965 5,441 5,616 Research and development ( 577 ) ( 601 ) ( 1,735 ) ( 1,767 ) Selling, general and administrative ( 265 ) ( 294 ) ( 841 ) ( 848 ) Amortization of acquisition-related intangible assets ( 29 ) ( 71 ) ( 108 ) ( 237 ) Total operating expenses ( 871 ) ( 966 ) ( 2,684 ) ( 2,852 ) Other income (expense) ( 5 ) ( 7 ) ( 15 ) ( 10 ) Operating income (loss) 990 992 2,742 2,754 Financial income (expense): Extinguishment of debt — — — — Other financial income (expense) ( 82 ) ( 75 ) ( 227 ) ( 231 ) Income (loss) before income taxes 908 917 2,515 2,523 Benefit (provision) for income taxes ( 173 ) ( 123 ) ( 468 ) ( 399 ) Results relating to equity-accounted investees ( 6 ) ( 2 ) ( 10 ) ( 5 ) Net income (loss) 729 792 2,037 2,119 Less: Net income (loss) attributable to non-controlling interests 11 5 22 19 Net income (loss) attributable to stockholders 718 787 2,015 2,100 Earnings per share data: Net income (loss) per common share attributable to stockholders in $ Basic 2.82 3.06 7.89 8.12 Diluted 2.79 3.01 7.80 8.03 Weighted average number of shares of common stock outstanding during the period (in thousands): Basic 254,458 257,488 255,501 258,744 Diluted 257,717 261,095 258,426 261,666 See accompanying notes to the Condensed Consolidated Financial Statements 3 CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) ($ in millions, unless otherwise stated) For the three months ended For the nine months ended September 29, 2024 October 1, 2023 September 29, 2024 October 1, 2023 Net income (loss) 729 792 2,037 2,119 Other comprehensive income (loss), net of

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.